Plandaí Biotechnology, Inc.
PLPLOTCFinancial Services● Active
$0.00
+$0.00(+900.00%)
Market Cap$4488953
P/E Ratio—
52W High$0.0001
52W Low$0.00001
Plandaí Biotechnology, Inc. (PLPL) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PLPL · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2017Report Date: Mar 31, 2017EPS Actual
-$0.00
Revenue
$0.00B
Fiscal Period
Q1 FY2017
FY ends December
Report Date
Mar 31, 2017
After Market Close
PLPL reports quarterly as a OTC-listed Shell Companies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q1 FY2017 | Mar 31, 2017 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2016 | Dec 31, 2016 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2016 | Sep 30, 2016 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2016 | Jun 30, 2016 | — | -$0.01 | — | $0.00B | — | — |
| — Q1 FY2016 | Mar 31, 2016 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2015 | Dec 31, 2015 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2015 | Sep 30, 2015 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2015 | Jun 30, 2015 | — | -$0.02 | — | $0.00B | — | — |
Q1 FY2017
Mar 31, 2017
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2016
Dec 31, 2016
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2016
Sep 30, 2016
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2016
Jun 30, 2016
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2016
Mar 31, 2016
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2015
Dec 31, 2015
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2015
Sep 30, 2015
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2015
Jun 30, 2015
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for PLPL.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2017 | Mar 31, 2017 | — | $0.02 | $0.02 | +0.00% |
| — Q4 FY2016 | Dec 31, 2016 | — | $0.03 | $0.03 | +19.69% |
| — Q3 FY2016 | Sep 30, 2016 | — | $0.01 | $0.01 | +4.32% |
| — Q2 FY2016 | Jun 30, 2016 | — | $0.03 | $0.03 | -4.58% |
| — Q1 FY2016 | Mar 31, 2016 | — | $0.07 | $0.07 | -2.99% |
| — Q4 FY2015 | Dec 31, 2015 | — | $0.05 | $0.05 | -2.99% |
| — Q3 FY2015 | Sep 30, 2015 | — | $0.12 | $0.12 | -0.08% |
| — Q2 FY2015 | Jun 30, 2015 | — | $0.22 | $0.23 | +3.60% |
Q1 FY2017+0.00%
Report Date
Mar 31, 2017
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q4 FY2016+19.69%
Report Date
Dec 31, 2016
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.03
Q3 FY2016+4.32%
Report Date
Sep 30, 2016
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q2 FY2016-4.58%
Report Date
Jun 30, 2016
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.03
Q1 FY2016-2.99%
Report Date
Mar 31, 2016
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.07
Q4 FY2015-2.99%
Report Date
Dec 31, 2015
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.05
Q3 FY2015-0.08%
Report Date
Sep 30, 2015
EPS Beat/Miss
—
Price Before
$0.12
Price After
$0.12
Q2 FY2015+3.60%
Report Date
Jun 30, 2015
EPS Beat/Miss
—
Price Before
$0.22
Price After
$0.23
Beat Rate0 / 8 quarters
Largest Move+19.69% (Q4 FY2016)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PLPL ends December
Plandaí Biotechnology, Inc. (PLPL) most recently reported earnings on March 31, 2017 for Q1 FY2017, posting EPS of $-0.00 (in line with the analyst consensus of —). The next PLPL earnings date is expected around September 1, 2026.
Each quarter, investors track PLPL earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PLPL revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PLPL's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PLPL earnings · 4 questionsPlandaí Biotechnology, Inc.'s next earnings report is expected around September 1, 2026. PLPL typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PLPL historically reports after market close (AMC).
PLPL earnings datewhen is PLPL earningsPLPL next earnings datewhen does PLPL report earningsPLPL earnings calendar
▸ Source: FMP · Plandaí Biotechnology, Inc. SEC filings · US GAAP · Plandaí Biotechnology, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026